Sign In
NewsRadar

Immunocore Ltd

Immunocore Limited is a privately owned, UK based biotechnology company developing a highly innovative platform technology that generates novel drugs called ImmTACs for the treatment of cancer and viral infection.

The company develops novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease.


• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Web:
Contact:
 
 
57c Milton Park
Abingdon OX14 4RX
United Kingdom
+44 (0)1235 438600
http://www.immunocore.com
Eliot Forster
+44 (0)1235 438600

Company Facts
Founded:
Founders:
CEO:Eliot Forster
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,837
Tech investments
From our Online Data Service
17,319
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Apr 2€6.0MOther Computers & Electronics
Apr 2€50.0MBiotechnology
Apr 2€0.7MMedical devices
Apr 2€0.9MWireless applications
Apr 2€100.0MContent management
Apr 1€416.0MOther Biotechnology & Healthcare

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.